New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 6, 2013
07:22 EDTRHHBY, GGG, CA, IOSP, GE, ASML, VLO, GWW, CHMT, AYIOppenheimer to host a conference
3rd Annual Investor 1-on-1 Conference is being held in London, England on February 6.
News For AYI;ASML;CA;CHMT;GE;GGG;GWW;IOSP;RHHBY;VLO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
November 14, 2014
14:53 EDTRHHBYCVS Express Scripts implementing drug price controls, says Cleveland Research
Cleveland Research believes that CVS (CVS) and Express scripts are implementing rebates and price controls on drug. The firm expects the companies to increase their focus on controlling durg prices next year, and adds that they have already itnroduced prior authorization criteria for hepatitis drug. Publicly traded drug companies include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY). Makers of hepatits c drugs include AbbVie (ABBV) and Gilead (GILD),
13:27 EDTRHHBYRoche reports FDA nod for Avastin in platinum-resistant recurrent ovarian cancer
Subscribe for More Information
09:38 EDTGEActive equity options trading
Subscribe for More Information
08:04 EDTGEGE Capital provides $37.5M credit facility to Specialty's Cafe & Bakery
Subscribe for More Information
08:00 EDTGEHalliburton, Baker deal would face 'intense' DOJ scrutiny, says Jefferies
Subscribe for More Information
November 13, 2014
11:12 EDTGEHungary to buy Budapest from GE Capital, Reuters reports
Subscribe for More Information
10:04 EDTGEGE opens $500M Brazil Technology Center
Subscribe for More Information
08:29 EDTCHMTChemtura announces restructuring, cost reduction plan
Chemtura announced a restructuring plan to reduce manufacturing conversion costs by approximately $50M, or about 10% annually, eliminate approximately $15M of annual stranded costs arising from the previously announced sale of the Chemtura AgroSolutions business, and reduce selling, general and administrative costs by at least $12M annually. Despite the success of many of Chemtura's improvement initiatives, the Company faces continuing weak demand conditions in some of the market applications it serves, as well as excess capacity in bromine and certain organometallics. While the company expects the bromine industry and electronics market to recover and grow to new heights, that growth may not occur in the coming year. The company expects to incur approximately $37M in cash costs to implement the restructuring plan, recording the majority of this expense in 4Q14 and 1Q15. The cash expenditures associated with these actions will continue into 3Q15. The company anticipates that the full run rate of the manufacturing and SG&A savings will be embedded in its performance by the third quarter of 2015, with annual savings of approximately $50M for the calendar year of 2015. Of the $15M of annual stranded costs, the company anticipates having eliminated them by 2Q15 with approximately $3M being incurred in the 1Q15.
07:26 EDTGEGE sees great infrastructure demand in developing markets, Reuters says
Subscribe for More Information
November 12, 2014
14:03 EDTGWWGrainger to increast investment in single channel online business
Subscribe for More Information
14:01 EDTGWWGrainger reiterates 16%-17% operating margins by 2019
The margin improvement is expected to come from organic sales growth in the high single digits and long term operating margin expansion averaging 30 to 60 basis points per year. For reference, Grainger's operating margin in 2014 is expected to be 14.3%, excluding restructuring charges and unusual items.
14:00 EDTGWWGrainger to refocus international portfolio, to exit Brazil
Subscribe for More Information
13:54 EDTGWWGrainger reports October sales increased 6% vs. last year
Grainger reported sales results for the month of October. Sales increased 6% versus October 2013. Results for the month included a 1 percentage point contribution from acquisitions, net of dispositions, and a 2 percentage points decline from unfavorable foreign exchange. Excluding acquisitions and foreign exchange, organic sales increased 7% driven by 6 percentage points of volume growth and a 1 percentage point contribution from sales of Ebola-related safety products. The month of October had 23 selling days, the same as October 2013. Q4 will have 64 selling days, the same as 4Q13.
13:51 EDTGWWGrainger expects FY15 EPS $12.90-$13.80, consensus $13.67
Subscribe for More Information
13:50 EDTGWWGrainger reiterates FY14 EPS guidance $12.20-$12.30, consensus $12.26
The company reiterated its sales growth forecast of 5%-5.5%, consensus $9.96B.
13:49 EDTGWWGrainger expects Q4 EPS $2.75-$2.85, consensus $2.83
Subscribe for More Information
11:17 EDTRHHBYLeerink major pharma & biotech analysts hold analyst/industry conference call
Subscribe for More Information
09:01 EDTGEGE to build advanced manufacturing facility in Pennsylvania
GE announced that it will build a new manufacturing facility to drive innovation and implementation of advanced manufacturing technologies across GE. The new facility represents a $32M investment over three years by the company and will result in the creation of 50 high-tech engineering jobs initially, in disciplines ranging from mechanical and electrical to systems and software engineering. These technologists will join GE’s global network of 50,000 world-class scientists, engineers, and skilled labor who are working to solve some of the world’s toughest challenges. The new facility reflects GE’s belief that the intersection of technology and manufacturing – marrying hardware with software – is bringing a new era of manufacturing. The site will be located outside of Pittsburgh in Findlay Township, PA to capitalize on the renowned academic institutions and skilled workforce in the area. Construction is expected to begin in March 2015 to be completed by September 2015.
08:05 EDTGEGoldman to hold a conference
Subscribe for More Information
07:22 EDTRHHBYAssociation of Molecular Pathology is holding annual meeting
2014 Annual Meeting of AMP is being held in National Harbor, Maryland on November 12-15.
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use